Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
2.920
-0.090 (-2.99%)
Apr 29, 2026, 10:00 AM EDT - Market open
Nyxoah Revenue
In the year 2025, Nyxoah had annual revenue of 10.02M EUR with 121.63% growth. Nyxoah had revenue of 5.64M in the quarter ending December 31, 2025, with 346.87% growth.
Revenue (ttm)
10.02M EUR
Revenue Growth
+121.63%
P/S Ratio
11.23
Revenue / Employee
54,575 EUR
Employees
184
Market Cap
132.16M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OraSure Technologies | 115.02M |
| Sanara MedTech | 103.12M |
| Pro-Dex | 72.10M |
| KORU Medical Systems | 41.13M |
| Utah Medical Products | 37.53M |
| Stereotaxis | 32.38M |
| Precision Optics Corporation | 24.42M |
| Zentek | 687.67K |
NYXH News
- 18 hours ago - Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 - GlobeNewsWire
- 5 weeks ago - Publication relating to transparency notifications - GlobeNewsWire
- 5 weeks ago - Nyxoah Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - GlobeNewsWire
- 6 weeks ago - Nyxoah Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference - Transcripts
- 6 weeks ago - Publication relating to transparency notification - GlobeNewsWire
- 6 weeks ago - Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference - GlobeNewsWire
- 7 weeks ago - Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 - GlobeNewsWire